相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of the Healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK
Benjamin D. Hunt et al.
JOURNAL OF PUBLIC HEALTH (2013)
Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes
Brian Buijsse et al.
EPIDEMIOLOGIC REVIEWS (2011)
Obesity 2 Health and economic burden of the projected obesity trends in the USA and the UK
Y. Claire Wang et al.
LANCET (2011)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
To what extent can deprivation inequalities in mortality and heart disease incidence amongst the working aged in Scotland be explained by smoking? Relative and absolute approaches
Frank Popham
HEALTH & PLACE (2011)
Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving
Ranee Chatterjee et al.
DIABETES CARE (2010)
Global healthcare expenditure on diabetes for 2010 and 2030
Ping Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study
L. A. Sargeant et al.
DIABETIC MEDICINE (2010)
Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies
J. M. P. Horgan et al.
JOURNAL OF PUBLIC HEALTH (2010)
Establishing a cardiovascular health and wellness program in a community pharmacy: Screening for metabolic syndrome
Julie L. Olenak et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2010)
Cardiovascular risk screening program in Australian community pharmacies
Gregory M. Peterson et al.
PHARMACY WORLD & SCIENCE (2010)
Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy
Juraporn Pongwecharak et al.
PHARMACY WORLD & SCIENCE (2010)
Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme
T. Karwalajtys et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service
Parastou Donyai et al.
PHARMACY WORLD & SCIENCE (2009)
Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988-1994 and 1999-2004
Jeffrey A. Cutler et al.
HYPERTENSION (2008)
Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy
I. Krass et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Personalised risk communication for informed decision making about taking screening tests
A. G. K. Edwards et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Sequential screening for diabetes - evaluation of a campaign in Swiss community pharmacies
Kurt E. Hersberger et al.
PHARMACY WORLD & SCIENCE (2006)
Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease
A Blenkinsopp et al.
JOURNAL OF PUBLIC HEALTH MEDICINE (2003)
The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program
M Jafari et al.
PHARMACOTHERAPY (2001)
A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study
KA Earle et al.
JOURNAL OF HUMAN HYPERTENSION (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Health promotion in community pharmacy: the UK situation
C Anderson
PATIENT EDUCATION AND COUNSELING (2000)